LEUKOTRIENES, LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA: AN UPDATE. PART I: SYNTHESIS, RECEPTORS AND ROLE OF LEUKOTRIENES IN ASTHMA

This publication has 100 references indexed in Scilit:

• Leukotriene B4Is the Functional Ligand Binding to and Activating the Cloned Chemoattractant Receptor, CMKRL1
  Biochemical and Biophysical Research Communications, 1997
• Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4synthase
  Canadian Journal of Physiology and Pharmacology, 1997
• Oral vs Inhaled Asthma Therapy
  Drugs, 1996
• Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy
  European Respiratory Journal, 1995
• Inhibition by a novel peptide leukotriene receptor antagonist ONO‐1078 of airway wall thickening and airway hyperresponsiveness to histamine induced by leukotriene C₄ or leukotriene D₄ in guinea‐pigs
  Clinical and Experimental Allergy, 1994
• Improving asthma treatment: the physiological message
  European Respiratory Journal, 1994
• 5‐lipoxygenase‐activating protein is an arachidonate binding protein
  FEBS Letters, 1993
• Asthma
  New England Journal of Medicine, 1992
• Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability.
  Journal of Clinical Investigation, 1989
• Thyroid and liver trophic changes in rats secondary to liver microsomal enzyme induction caused by an experimental leukotriene antagonist (L-649,923)
  Toxicology and Applied Pharmacology, 1988